Abstract:Observational studies in preterm newborns suggest that delay in administering amino acids (AA) could result in a protein catabolic state and impact on growth and development. The objective of this review was to compare the efficacy and safety of early versus late administration of intravenous AA in neonates born at < 37 weeks of gestation. We searched CENTRAL, MEDLINE, Embase, and trial registries in March 2023. We checked the reference lists of included studies and studies/systematic reviews where subject matter related to the intervention or population examined in this review. We included randomised controlled trials (RCTs) comparing early administration of AA with late administration in premature newborn infants. We defined early administration of AA solution as the administration of AA in isolation or with total parenteral nutrition within the first 24 hours of birth, and late administration as the administration of AA in isolation or with total parenteral nutrition after the first 24 hours of birth. We used standard Cochrane methodological procedures. We used the GRADE approach to assess the certainty of the evidence. Nine studies (383 participants) were eligible for inclusion in the review. All study participants were born at < 37 weeks of gestation and were inpatients in neonatal intensive care units. No studies reported growth during the first months of life as assessed by difference in weight. Early administration of AA may have little or no effect on growth in the first month of life as measured by length (mean difference (MD) 0.00, 95% confidence interval (CI) −0.41 to 0.41; 1 study; 21 participants; low‐certainty evidence) and head circumference (MD 0.05, 95% CI −0.03 to 0.14; 2 studies; 87 participants; low‐certainty evidence). No studies reported the discharge weight outcome. Early administration of AA may result in little to no difference in neurodevelopmental outcome assessed by Mental Developmental Index (MDI) of < 70 at two years of age (odds ratio 0.83, 95% CI 0.21 to 3.28; 1 study; 111 participants; low‐certainty evidence). No studies reported all‐cause mortality at 28 days and before discharge. Early administration of AA may result in a large increase in positive nitrogen balance in the first three days of life (MD 250.42, 95% CI 224.91 to 275.93; 4 studies; 93 participants; low‐certainty evidence). Low‐certainty evidence suggests that there may be little to no difference between early and late administration of AA in growth (measured by length and head circumference during the first month after birth) and neurodevelopmental outcome (assessed by MDI of < 70). No RCTs reported on weight in the first month of life, mortality (all‐cause mortality at 28 days and before discharge), or discharge weight. Low‐certainty evidence suggests a large increase in positive nitrogen balance in preterm infants who received AA within 24 hours of birth. The clinical relevance of this observation is unknown. The number of infants in the RCTs included in the review was small, and there was clinical heterogeneity amongst trials. Adequately powered trials in infants < 37 weeks' gestation are required to determine optimal timing of initiation of AA. We identified two ongoing studies. Both studies will be recruiting infants ≥ 34 weeks of gestation and may or may not add to the outcome data for this review. Key message Due to lack of strong evidence, the benefits of giving amino acids early to babies who were born before 37 weeks of pregnancy are unclear. What are amino acids? Amino acids are the building blocks that combine to form proteins. Our body makes some amino acids, but it cannot make the nine essential amino acids that we need from our diet. Protein is crucial for healthy growth and development. Newborn babies ingest essential amino acids from breast and formula milk. What is prematurity, and what are some of the risks of prematurity in babies? Premature babies have limited reserves of energy and may not be able to feed soon after birth. This often results in a need for their nutrition to be administered in a vein (parenteral nutrition). What did we want to find out? We wanted to find out if giving amino acids within the first 24 hours of birth compared to after the first 24 hours of birth to babies born before 37 weeks of pregnancy improved growth and development, decreased the chance of death, and affected some normally occurring chemicals in the blood. What did we do? We searched for studies in which babies who were born before 37 weeks of pregnancy randomly received amino acids early (within 24 hours of birth) or late (after 24 hours of birth). What did we find? We found 9 reports (383 babies) in our search. However, not all of our outcomes of interest were reported in every study. Limited data from a few babies suggest that early amino acids may not result in any improvem -Abstract Truncated-

Clinical Outcomes of Special Amino Acids for Parenteral Nutrition in Neonates

L-arginine supplementation improved neonatal outcomes in pregnancies with hypertensive disorder or intrauterine growth restriction: A systematic review and meta-analysis of randomized controlled trials

[Intensive Early Amino Acid Supplementation is Efficacious and Safe in the Management of Preterm Infants].

Expert consensus on clinical use of compound amino acid injection

The Proper Amino Acid Administration in Parenteral Nutrition in Very Low Birth Weight Infants

Clinical Effect of Multi-Oil Fat Emulsion for Parenteral Nutrition Support in Extremely Low Birth Weight Infants

[M-mode and two dimensional echocardiography for evaluation of mitral stenosis (author's transl)].

Meta-analysis of effectiveness and safety of early different doses of amino acid supplementation in preterm infants

Effect of Early Large Dose of Amino Acids on Growth and Metabolism of Small Preterm Infants

Low- versus High-Dose and Early versus Late Parenteral Amino-Acid Administration in Very-Low-Birth-Weight Infants: A Systematic Review and Meta-Analysis

Pharyngolaryngectomy with total esophagectomy following concomitant chemoradiotherapy for advanced and/or salvage cases of hypopharyngeal carcinomas

Early versus late administration of amino acids in preterm infants receiving parenteral nutrition

The effects of amino acid contents in parenteral nutrition on serum electrolytes in preterm infants

Parenteral amino acid intakes in critically ill children: a matter of convenience

Risk factors and outcomes of parenteral nutrition-associated cholestasis in high-risk preterm infants

Early Energy Intake and Amino Acid Profile in Preterm Newborns: A Quasi-Experimental Study

HAEMATOLOECHUS DANBROOKSI N. SP. (DIGENEA: PLAGIORCHIOIDEA) FROM RANA VAILLANTI FROM LOS TUXTLAS, VERACRUZ, MEXICO

Parenteral Cysteine Supplementation in Preterm Infants: One Size Does Not Fit All

Efficacy of High Branched-Chain Amino Acids in Surgical Patients with Liver Dysfunction Requiring Parenteral Nutrition

Clinical Study of Nutritive Value on Premature Infant Fed Long-chain Polyunsatu rated Fatty Acids Enrichment Formula

Research progress of Alanyl-glutamine clinical application